Life Sciences

Waleed Hassanein

Waleed Hassanein
CEO, TransMedics
I am very impressed with Adam Grosser's ability to focus on the critical aspects of our business and the uncommon value proposition of our organ transplant technology. Their entrepreneurial and operational experience makes Foundation Capital the perfect partner for TransMedics as we transform organ transplant medicine.

www.transmedics.com

Headquartered in Andover, Massachusetts, TransMedics™ is a medical device company founded in 1998 to address the unmet need for better, more effective organ transplant technologies. The Company has developed the first commercial, portable warm blood perfusion system that allows for a new type of organ transplant, called a living organ transplant. This technology, called an Organ Care System, or OCS, is designed to maintain organs in a warm, functioning state outside of the body during transport from organ donor to recipient.

TransMedics’ mission is to enable more patients with end stage organ failure to benefit from the accepted medical standard of care — organ transplantation. TransMedics' Organ Care System is designed to deliver the healthiest organ, thereby potentially increasing the number of available organs, improving patient outcomes, and reducing recovery time, hospital stays and reliance on ongoing medical therapies.

Foundation Capital Partner:

Adam Grosser

TransMedics News:

No News Available

TransMedics Jobs:

No Jobs Available